| Product Specification | Details |
|---|---|
| Brand Name | Dayvigo |
| Generic Name | Lemborexant |
| Strength | 5 mg |
| Dosage Form | Film-coated tablets |
| Therapeutic Category | Insomnia treatment |
| Drug Class | Dual orexin receptor antagonist |
| Route | Oral |
| Brand Manufacturer | Eisai |
| Pack Size Shown | 2 × 14 tablets |
| Prescription Status | Prescription-only |
| Storage | Follow approved package labeling; pictured carton states below 30°C |
| Export Availability | Subject to confirmation |
| International Supply | Subject to destination-country regulatory approval |
Note: These specifications are based partly on the pictured packaging. Product authenticity, current manufacturer details, batch information, and market-specific labeling must be verified against the actual stock and approved product documentation.
2. What Is Dayvigo 5 mg?
Dayvigo contains Lemborexant, a dual orexin receptor antagonist used to treat adults with insomnia, including difficulties falling asleep or staying asleep.
Orexin is a neuropeptide system involved in promoting wakefulness. Lemborexant blocks orexin receptors OX1R and OX2R, helping reduce wakefulness and support sleep.
Dayvigo is not a traditional benzodiazepine sleeping medicine.
Key product characteristics
Contains Lemborexant 5 mg per tablet.
Used for treating insomnia in adults.
Works through orexin receptor antagonism.
Requires medical supervision and a valid prescription.
Can cause next-day impairment, drowsiness, and other adverse effects.
May be subject to additional controlled-substance requirements in certain markets.
Important: Dayvigo should be used only under the supervision of an appropriately qualified healthcare professional. It is not suitable for every patient.
3. Dayvigo 5 mg Packaging and Storage Information
For international pharmaceutical buyers, product packaging and storage conditions are important factors in procurement decisions.
The supplied Dayvigo 5 mg packaging image shows a carton containing 2 × 14 tablets (28 tablets total).
Before accepting an international shipment, buyers should verify:
Original manufacturer packaging and tamper evidence.
Batch number and manufacturing date.
Expiry date and remaining shelf life.
Approved labeling and package insert.
Applicable storage conditions.
Invoice and batch traceability records.
Products should be transported and stored according to the manufacturer's approved instructions. Temperature monitoring and protective shipping arrangements may be required depending on the shipment route and applicable quality standards.
4. Dayvigo 5 mg Wholesale Supply from India
India is an important participant in international pharmaceutical manufacturing and distribution.
Licensed overseas pharmaceutical businesses may explore India-based sourcing channels for prescription medicines, provided the transactions comply with all relevant laws.
For Dayvigo 5 mg, an international procurement process should include verification of the supplier's authorization, product authenticity, export eligibility, and import approval.
Typical international sourcing process
The overseas buyer submits a product enquiry with quantity and destination country.
The supplier confirms whether authentic, legally exportable stock is available.
Both parties review required pharmaceutical licenses and product documentation.
The buyer verifies import authorization and any controlled-drug requirements.
Commercial terms, shipping arrangements, and payment conditions are agreed.
The shipment is prepared with legally required documentation.
The importer completes customs and regulatory clearance.
Availability and shipment acceptance cannot be guaranteed until the regulatory and commercial checks have been completed.
5. Target Countries for Dayvigo 5 mg Pharmaceutical Trade Enquiries
BizHQ can receive sourcing enquiries from licensed pharmaceutical buyers in the following markets. Inclusion in this list does not establish that Dayvigo is approved, available, or legally importable in a particular country.
North America
United States, Canada, Mexico
Buyers should check the relevant national drug approval, importer licensing, and controlled-substance requirements. In the United States, Lemborexant is a Schedule IV controlled substance, so ordinary pharmaceutical export documentation alone is insufficient.
Europe
United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Ireland, Poland, Portugal
European buyers must verify national marketing authorization, import permissions, distribution licensing, and applicable GDP requirements. Requirements differ between the United Kingdom, European Union member states, and Switzerland.
Middle East
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain, Jordan
Importers should confirm product registration, importer eligibility, and any additional permissions relating to prescription or controlled medicines.
Asia-Pacific
Australia, New Zealand, Singapore, Malaysia, Thailand, Philippines, Vietnam, Indonesia, Japan, South Korea
Buyers must review the relevant medicines regulator's requirements, including product registration, import licensing, and applicable scheduling restrictions.
Africa
South Africa, Nigeria, Kenya, Ghana, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, Mauritius
Importers should confirm national medicines registration requirements, licensed distribution status, and whether exceptional import authorization is available where applicable.
Latin America
Brazil, Chile, Colombia, Peru, Argentina, Ecuador, Costa Rica, Panama
Regulatory approvals, product registration, import authorization, and customs documentation should be checked before procurement.
Regulatory reminder: International shipment is possible only where the particular product and transaction are lawful. A buyer's enquiry does not constitute confirmation of supply eligibility.
6. Documentation Required for International Pharmaceutical Imports
Documentation varies by destination country, product status, and shipment structure.
Commonly requested documents include:
Commercial invoice and packing list.
Certificate of Analysis (COA), where applicable.
Certificate of Origin (COO), if required.
Manufacturer or distributor authorization, where applicable.
Relevant wholesale or export licenses.
Product registration or marketing authorization evidence.
Import permits and controlled-substance permits, when required.
Shipping and customs documents.
Batch and expiry information.
Additional documentation may be necessary depending on the regulatory authority and local laws.
7. Why International Buyers Contact BizHQ
For pharmaceutical importers, selecting a sourcing partner requires attention to product authenticity, documentation, communication, and regulatory compliance.
BizHQ provides a contact channel through Medicine India Export for international pharmaceutical product enquiries.
Buyers can contact the team to discuss product specifications, requested quantities, destination markets, documentation needs, and commercial requirements.
All product sourcing requests remain subject to verification of actual stock, supplier eligibility, and the legal requirements of the destination market.
8. Frequently Asked Questions About Dayvigo 5 mg International Trade
Q1. What is Dayvigo 5 mg?
Dayvigo 5 mg is a prescription medicine containing Lemborexant, used to treat insomnia in adults.
Q2. Who manufactures Dayvigo?
Dayvigo is an Eisai-branded pharmaceutical product. Buyers should verify the actual manufacturing site and authorized distribution chain for the specific market and batch.
Q3. Can Dayvigo 5 mg be exported from India?
A shipment may be considered only after verifying that the product can legally be sourced and exported from India and imported into the destination country. Applicable controlled-substance and product authorization requirements must also be satisfied.
Q4. Is Dayvigo 5 mg available for wholesale orders?
Wholesale availability must be confirmed with an appropriately licensed supplier. Buyers can submit an enquiry specifying their required quantity and destination.
Q5. What is the pack size of Dayvigo 5 mg?
The supplied product image shows a pack size of 2 × 14 tablets. Packaging can vary by market.
Q6. Does Dayvigo require a prescription?
Yes. Dayvigo is a prescription-only medicine. Its legal scheduling and additional distribution restrictions depend on the country.
Q7. Can pharmaceutical distributors in the USA import Dayvigo from India?
Importing a controlled prescription medicine into the United States involves FDA, DEA, customs, and other applicable legal requirements. A distributor must independently establish whether the proposed import is authorized; ordinary commercial import procedures are not sufficient.
Q8. Can Dayvigo be supplied to the UK, UAE, Australia, and Canada?
Any proposed supply requires confirmation of the product's legal status, import authorization, and other country-specific requirements. Enquiries may be submitted, but shipment availability is not guaranteed.
Q9. What is the minimum order quantity (MOQ)?
MOQ depends on legally available stock, supplier conditions, packaging, and destination-country requirements. It must be confirmed by quotation.
Q10. What is the shelf life of Dayvigo 5 mg?
The shelf life and remaining expiry period should be verified from the approved product documentation and the specific batch supplied.
Q11. Can BizHQ provide export documentation?
Buyers can enquire about required documentation. The availability and suitability of each document must be verified for the actual transaction.
Q12. How can international pharmaceutical buyers request a quotation?
Licensed buyers can contact BizHQ through its website, email, or WhatsApp and provide the product name, quantity, destination country, and relevant business licensing information.
9. Contact BizHQ for Dayvigo 5 mg Pharmaceutical Sourcing Enquiries
For international pharmaceutical procurement enquiries relating to Dayvigo 5 mg (Lemborexant Tablets), contact BizHQ through Medicine India Export.
Business Name: BizHQ
Website: www.medicineindiaexport.com
Email: sales.medindiaexport@gmail.com
WhatsApp: +91 7218129896
